Pfizer : PFE

All Pfizer Articles

1491 Articles

Vandita Jadeja | Apr 17, 2026 at 10:22 AM EDT

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record…

Lee Jackson | Apr 16, 2026 at 7:57 AM EDT

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Pre-Market Stock Futures: The futures are trading modestly higher after a wild Wednesday that saw the Nasdaq explode higher to…

Drew Wood | Apr 14, 2026 at 9:00 AM EDT

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Two million dollars in four household-name dividend payers can generate between $132,000 and $146,000 in annual income. That is the…

Drew Wood | Apr 14, 2026 at 8:00 AM EDT

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

A million dollars sounds like enough to retire on. Whether it actually is depends entirely on what you make it…

Vandita Jadeja | Apr 6, 2026 at 12:15 PM EDT

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

Pharmaceutical companies AbbVie (NYSE:ABBV | ABBV Price Prediction) and Pfizer (NYSE:PFE) both reported fourth-quarter earnings in early February, revealing two…

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

Trey Thoelcke | Mar 26, 2026 at 7:55 AM EDT

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

Pfizer (NYSE: PFE | PFE Price Prediction) is one of the most widely held dividend stocks among retirement investors. The…

Joey Frenette | Mar 25, 2026 at 12:23 PM EDT

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

It’s rare to get such a massive high-yielder that’s also positioning itself for long-term growth. Of course, shares of Pfizer…

Joel South | Mar 24, 2026 at 10:52 AM EDT

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

Pfizer (NYSE:PFE | PFE Price Prediction) has quietly built momentum in 2026, with shares up 6.61% year-to-date and 2.70% over…

Lee Jackson | Mar 18, 2026 at 7:19 AM EDT

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on…

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…

Vandita Jadeja | Feb 11, 2026 at 10:00 AM EST

Ultra-High Yield Dividend Stocks Yielding More Than 5%

Choosing the right investment vehicles can ensure steady income and wealth generation. Growth stocks are often considered to be an…

David Moadel | Feb 6, 2026 at 3:37 PM EST

3 High-Yield Dividend Stocks Perfect For Retirees

What does a successful retirement look like? If it means financial security through steady income sources, then you can get…

Lee Jackson | Feb 6, 2026 at 7:45 AM EST

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

These five quality stocks come with at least a 6% dividend and are likely to raise their dividends year in…

Vandita Jadeja | Jan 31, 2026 at 8:28 PM EST

Passive Income Investors Will Love These Cheap Dividend Stocks

Passive income can help secure your retirement, but building a dependable income is not easy. You must be able to…

1 2 3 4 5 … 100

Pfizer : PFE

All Pfizer Articles

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

Passive Income Investors Will Love These Cheap Dividend Stocks

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

Pfizer : PFE

All Pfizer Articles

AbbVie vs. Pfizer: One Pharma Dividend Has a Moat — The Other Is Praying for a Pipeline Hit

Here Are Thursday’s Top Wall Street Analyst Research Calls: Autoliv, CoreWeave, Corning, Dicks Sporting Goods, Federated Hermes, Gitlab, PayPal, Pfizer, Okta, and More

Build a Six Figure Dividend Stream With Four Blue Chip Names and $2 Million

Four Tickers That Turn $1 Million Into $60,000 of Annual Income

High Yield vs. Sustainable Growth: Why AbbVie’s Dividend Beats Pfizer’s Despite the Lower Payout

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Income Investors Face a Hard Truth About Pfizer’s Payout Safety

This 6.5%‑Yielding Dividend Payer is Sitting on a Breakthrough Investors Haven’t Priced In

Pfizer Could Hit $36 by Year-End as Analysts See 2-to-1 Payoff on Key Prostate Cancer Trial

20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Ultra-High Yield Dividend Stocks Yielding More Than 5%

3 High-Yield Dividend Stocks Perfect For Retirees

5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now

Passive Income Investors Will Love These Cheap Dividend Stocks

Forget P&G: This Defensive Cash-Flow Powerhouse Just Beat Earnings and Is a Best Buy Today

Up 23% From Its 52-Week Low: 1 Critical Metric That Explains Why I’m Standing Pat on Coca-Cola Stock

This $15 Billion Operational Beat Just Rewrote the Entire Bear Thesis for AbbVie

Featured Reads

The 1 Number That Might Make You Change Your Mind About When to Claim Social Security

How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check